Earnings preview · PFE
Pfizer earnings preview (November 3): what analysts expect
Pfizer Inc. reports its Jul-Sep 2026 quarter on Tuesday, November 3. Here is what the market expects and how it gets there, in charts.
InbestPlanners · Updated Oct 30, 2026 · 3 min read
Tuesday, November 3
Results day · call at 10:00 AM ET · confirmed date
In 30 seconds
- Expected earnings per share: $0.73 (-16.3% on the same quarter a year ago).
- Expected sales: $15.9B (-4.7% year on year).
- It beat the earnings estimate in 4 of its last 4 quarters.
- The share arrives up 22.0% over three months and up 34.5% over a year.
Expected EPS
$0.73
-16.3% vs. a year ago
Expected sales
$15.9B
-4.7% y/y
Beat estimates
4 / 4
last quarters
Share, 12 months
+34.5%
Close $30.52
Earnings per share: expected against reported
Every quarter analysts publish how much they think Pfizer will earn per share. The grey bar is their estimate; the coloured one, what the company reported. On the right, what they expect now (19 analysts), with the lowest and highest estimate.
Jul-Sep
2025
Beat
Oct-Dec
2025
Beat
Jan-Mar
2026
Beat
Apr-Jun
2026
Beat
Jul-Sep
2026
Now
In the last 4 quarters it beat the estimate 4 times. On average, reported earnings came in 17.6% above the estimate.
Sales and margins
Sales each quarter, in billions of USD; the dotted bar is what is expected now: $15.9B, against $16.7B a year earlier.
Apr-Jun
2025
Jul-Sep
2025
Oct-Dec
2025
Jan-Mar
2026
Apr-Jun
2026
Jul-Sep
2026
| Quarter | Gross margin | Operating margin | Net income |
|---|---|---|---|
| Apr-Jun 2025 | 74.2% | 25.7% | $2.9B |
| Jul-Sep 2025 | 75.0% | 33.2% | $3.5B |
| Oct-Dec 2025 | 70.0% | 21.0% | $-1.6B |
| Jan-Mar 2026 | 75.4% | 29.5% | $2.7B |
| Apr-Jun 2026 | 72.8% | 23.5% | $-248.0M |
What to watch on November 3
- 01
Earnings per share
The benchmark is $0.73. Above it, the market reads "beat".
- 02
Sales
$15.9B expected. Profit can beat through cuts; sales tell whether the business grows.
- 03
Gross margin
Last quarter it was 72.8%. If it falls, it sells cheaper or produces at a higher cost.
Calendar: the next ex-dividend date is Friday, November 6.
Frequently asked questions
When does Pfizer report earnings?
Pfizer reports its Jul-Sep 2026 quarter on Tuesday, November 3. The analyst call is at 10:00 AM ET.
What EPS do analysts expect from Pfizer?
The consensus of 19 analysts is $0.73 per share, with estimates from $0.56 to $0.83. A year ago it was $0.87.
What sales are expected from Pfizer?
Analysts expect sales of $15.9B, against $16.7B a year ago.
Does Pfizer usually beat estimates?
In the last 4 quarters it beat the EPS estimate 4 times; on average reported earnings came in 17.6% above the estimate. Having done it before says nothing about this time.
Information, not investment advice. Figures are the data provider's (analyst consensus and accounts published by Pfizer Inc.) as of Oct 30, 2026; EPS is the one analysts compare and may differ from reported GAAP figures. Quarters are calendar quarters (Jul-Sep 2026), whatever the company's fiscal numbering. Past performance does not guarantee future results.